Category: Agriculture
-
The Inflection Point: It’s now or never for Plus Products (PLUS.C)
When weed legalized in Canada, I wasn’t a consumer participant. Smoking up has never been my jam. I know some like the ritual of it all, but I see having to prep and grind and smoke as being similar to driving stick – I mean, why not also stop your car by cutting two holes…
-
Tilray (TLRY.Q) financials are nightmare fuel: Quarterly net loss down 16% to ‘just’ $184m
If Tilray (TLRY.Q) will leave any sort of legacy on the Canadian cannabis landscape, it will be that, for a short time and by virtue of a well-timed and paper-lined public listing, the CEO was the highest paid CEO in North America. For a hot minute, Americans bought in by the truckload and drove the…
-
Speakeasy (EASY.C) completes $2m loan with interest rate just 5% shy of what’s considered loan sharking
I break laws sometimes. I speed on the highway. I possess more than the 30 gram legal limit of weed products. I sneak food into the cinema, or used to when the cinema was a thing we did in polite society. I’ve been drunk and disorderly, broken noise bylaws on a Saturday night, and I…
-
Revive Therapeutics (RVV.C): Kicked around, called a fraud, gets FDA approval of Phase 3 COVID-19 trials
“Let them say what they want, we know what we’re doing, and we’re doing the work,” Michael Frank told me a month ago, as he put out news claiming his little pharma company, which had built a reputation for chasing aggressively into new pharmaceutical fields, had found some IP that might be useful in the…
-
Revive Therapeutics (RVV.C) warned about overhype, but up 26% on clinical trial news
Oddball pharmaceutical player Revive Therapeutics (RVV.C) found itself on the back end of a warning by the BCSC this week, that certain German players in the smallcap promotion space had over-hyped the mushroom/cannabis/biotech deal and promised big wins inappropriately for anyone who invested. As a marketing partner of Revive, I got a few panicky texts…
-
Revive Therapeutics (RVV.C) finds pharma asset under the couch that may treat COVID-19
When new sectors emerge, as cannabis did in 2013 and psychedelics are doing right now, microcap companies that have struggled in other sectors will often pivot into new business. Miners become weed companies, then biotech companies, then shroom companies, as boards and management pursue new opportunities that might one day prove better than the last.
-
Shroom stocks go nuts: First movers SHRM, MMED, RVV up hard as gamblers gamble
Today was a day that daytraders have been looking forward to for some time; the day that shroom stocks finally gripped the road and took off. Mind Medicine (MMED.E) ripped 90% to $0.77 on the back of 15m shares traded, reminding anyone who’d listen that ex-Canopy CEO Bruce Linton and pretend billionaire Kevin O’Leary were on…
-
Gaia Grow (GAIA.V) sells hemp, buys cannabis stores
The deal proposes that Gaia will acquire “all of the share capital of 1202465 B.C. (Nelson store) and Patriot Cannabis Brands (2 Powell River stores) from Blackhawk.